Close
FINDING CURES TOGETHER<sup>SM</sup>

Media Advisories

 

 

AACR to Host a Congressional Briefing to Unveil the AACR Cancer Progress Report 2018255409/12/2018 1:06:00 PMhttps://www.aacr.org/Newsroom/Lists/Media Advisories/AllItems.aspx105False2018-09-12T04:05:00Z<div class="ExternalClass38730240A56344C392B773CE8FD86B7D"><p><strong>WHAT&#58;&#160; &#160; &#160;</strong>&#160; &#160; &#160;<br>American Association for Cancer Research (AACR) to host a Congressional briefing to unveil the <em>AACR Cancer Progress Report 2018</em>.&#160;</p><p>In its eighth year, the AACR Cancer Progress Report showcases progress against cancer from the past year, and underscores the importance of robust, sustained, and predictable growth in funding for the National Institutes of Health, National Cancer Institute, U.S. Food and Drug Administration, and Cancer Prevention and Control Programs at the Centers for Disease Control and Prevention.</p><p><strong>WHO&#58;&#160; </strong>&#160; &#160; &#160;<br>U.S. Rep. Ted Poe (R-Texas 2nd District)</p><p>Elizabeth Jaffee, MD, President, American Association for Cancer Research;&#160;<em>Chair, AACR Cancer Progress Report 2018</em>; Deputy Director, Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins University, Baltimore<br></p><p>Margaret Foti, PhD, MD (hc), CEO, American Association for Cancer Research, Philadelphia&#160;</p><p>Quynh-Thu Le, MD, Professor and Chair, Department of Radiation Oncology, Stanford Cancer Institute, Palo Alto, California</p><p style="text-decoration&#58;underline;">Survivor Stories from the <em>AACR Cancer Progress Report 2018</em>&#58;</p><p>Chuck Dandridge, survivor of acute myeloid leukemia, Mansfield, Texas</p><p>Tori Lee, pediatric cancer survivor of acute lymphoblastic leukemia with Tori’s parents, Dana and Chris Lee, Oakhurst, New Jersey</p><p>Laurie Trotman, survivor of breast cancer, Hoover, Alabama</p><p><strong>WHEN&#58;&#160; &#160; </strong>&#160; &#160; &#160; <br>Wednesday, September 12, 2018<br><strong>12 p.m. to 1&#58;30 p.m.</strong></p><p>For in-person attendance, please RSVP to Rachel Salis-Silverman, <a href="mailto&#58;Rachel.silverman@aacr.org">Rachel.silverman@aacr.org</a>.&#160;&#160;</p><p><strong>WHERE&#58;&#160; &#160; </strong>&#160; &#160;<br>Rayburn House Office Building<br>The Gold Room (Room 2168)<br>Capitol Hill</p><p><em>Briefing is in cooperation with U.S. Representative Kevin Yoder (R-Kansas).</em></p></div>
Congressional Leaders and NIH Director Francis Collins to Speak at Rally for Medical Research 255429/12/2018 1:05:37 PMhttps://www.aacr.org/Newsroom/Lists/Media Advisories/AllItems.aspx106False2018-09-12T04:05:00Z<div class="ExternalClass962031C1036742E09E759ABC05A5F00A"><p>​Nearly 350 organizations will converge on Capitol Hill for Rally for Medical Research Hill Day on September 12 and 13 to advocate for robust, sustained, and predictable annual funding increases for the National Institutes of Health (NIH). Specifically, advocates will express their appreciation to Senate offices for passing a bill with a $2 billion funding increase for the NIH in fiscal year (FY) 2019, while requesting that the House of Representatives support the Senate-passed funding level of $39.1 billion for the NIH in the final FY 2019 Labor-HHS-Education Appropriations Bill.</p><p>The media is invited to cover the following events&#58;<br></p><p><b>A Reception to Celebrate the Lifesaving Science Supported by the NIH<br></b>Wednesday, September 12, 4&#58;30 p.m. to 7 p.m.<br>Dirksen Senate Office Building, Room G50<br>Moderated by Elizabeth Jaffee, President of the American Association for Cancer Research (AACR) and Deputy Director of the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins University</p><p>Confirmed Speakers&#58;<br>Francis S. Collins, MD, PhD, Director, National Institutes of Health<br>Senator Roy Blunt (R-Missouri)<br>Senator Patty Murray (D-Washington)<br>U.S. Rep. Kevin Yoder (R-Kansas)<br></p><p><b>Rally for Medical Research Breakfast Program<br></b>Thursday, September 13, 8 a.m.<br>Watergate Hotel, 2650 Virginia Ave., NW, Washington, D.C.<br>Moderated by Margaret Foti, PhD, MC (hc), Chief Executive Officer of the American Association for Cancer Research (AACR)</p><p>Confirmed Speakers&#58;<br>U.S. Rep. Debbie Wasserman Schultz (D-Florida)<br>U.S. Rep. Jamie Raskin (D-Maryland)</p><p><strong>About Rally for Medical Research Hill Day<br></strong>The Rally for Medical Research initiative was launched in April 2013 to bring together the entire medical research community to ask Congress to make the NIH a national priority. Through the annual Hill Day, the Rally for Medical Research continues to raise awareness about the critical need for an increased investment in the NIH to improve health, spur progress, inspire hope, and save more lives.</p><p>Following more than a decade of NIH budgets that failed to keep up with the rate of biomedical inflation, Congress has redoubled its efforts to support lifesaving research by boosting the NIH budget by a remarkable $7 billion (23 percent) since FY 2015. For the benefit of all those who continue to await better therapies and even cures, this momentum must continue.</p><p>This investment is enabling researchers at universities and research institutions in all 50 states to pursue emerging scientific opportunities to address the nation’s most pressing health needs. In addition to bringing hope and improving the quality of life for patients, the ongoing success of the medical research enterprise also drives local and national economic activity, strengthens U.S. competitiveness in an increasingly innovation-based global marketplace, and inspires future generations of scientists to commit to careers in research.<br></p></div>
Media Registration: Cancer Immunotherapy Conference in New York 251907/31/2018 8:03:48 PMhttps://www.aacr.org/Newsroom/Lists/Media Advisories/AllItems.aspx104False2018-07-31T04:00:00Z<div class="ExternalClassA5FCB38FBF8A41D48DE08E23AB1EDEA6"><p>NEW YORK – The Cancer Research Institute (CRI), the Association for Cancer Immunotherapy (CIMT), the European Academy of Tumor Immunology (EATI), and the American Association for Cancer Research (AACR) will sponsor the fourth <a href="http&#58;//www.cancerimmunotherapyconference.org/">International Cancer Immunotherapy Conference</a> at the New York Marriott Marquis in New York City, Sept. 30-Oct. 3, 2018.<br></p><p>The program will focus on “Translating Science into Survival” and feature talks from more than 60 leaders in the field. The conference will cover all areas of inquiry in cancer immunology and immunotherapy, including&#58; regulating T cells; the tumor microenvironment; genetically engineered T cells; the effects of targeted and immune therapies on immune balance; novel vaccine platforms and combinations; predicting response to immunotherapy; the convergence of technology and cancer immunotherapy; and the microbiome and metabolism.<br></p><p>The full program is available <a href="http&#58;//www.cancerimmunotherapyconference.org/program-of-events">here</a>.<br></p><p><strong>Registration is complimentary for credentialed news media. Contact </strong><a href="mailto&#58;communications@aacr.org"><strong>communications@aacr.org</strong></a><strong> to register.&#160;</strong><br></p><p>Cancer center public information officers and communications staff can also register by contacting <a href="mailto&#58;communications@aacr.org">communications@aacr.org</a>.&#160;<br></p><p>Those following on social media can join the conversation on Twitter at <a href="mailto&#58;communications@aacr.org">#cicon18</a>.<br></p><p><br></p><p>For more information, contact the AACR public relations team&#58;<br></p><p>Rachel Salis-Silverman<br></p><p>Director</p><p>215-446-7159</p><p>Cell&#58; 267-970-3685</p><p></p><a href="mailto&#58;rachel.silverman@aacr.org"><p>rachel.silverman@aacr.org<br></p></a><p>&#160;</p><p>Julia Gunther</p><p>Assistant Director&#160;</p><p>215-446-6896</p><p>Cell&#58; 770-403-7690</p><p><a href="mailto&#58;julia.gunther@aacr.org">julia.gunther@aacr.org</a></p><p>&#160;</p><p>Sarah Cohn</p><p>Manager</p><p>215-446-8754</p><p>Cell&#58; 856-397-0314</p><p></p><a href="mailto&#58;sarah.cohn@aacr.org"><p>sarah.cohn@aacr.org<br></p></a><p>&#160;</p><p>Charmaine Riley</p><p>Senior Coordinator</p><p>215-309-4347</p><p>Cell&#58; 360-789-5147</p><p><a href="mailto&#58;charmaine.riley@aacr.org">charmaine.riley@aacr.org</a><br></p></div>
Video Available: AACR Hosts Congressional Briefing on the Alarming Rise of E-cigarette Use in Youth250717/19/2018 8:35:07 PMhttps://www.aacr.org/Newsroom/Lists/Media Advisories/AllItems.aspx103False2018-07-19T20:30:00Z<div class="ExternalClass5AAEA9BA0A06458081E93C9FB8F62AA8"><p>WASHINGTON, D.C. – Scientists from the American Association for Cancer Research (AACR), along with an expert from the federal government, an official from a local school district, and a writer from The New Yorker, addressed congressional staffers and the public on Wednesday, July 18 at a briefing titled “E-cigarettes&#58; Striking a Balance Between Preventing Youth Nicotine Addiction and Helping Current Smokers Quit Combustible Cigarettes.”&#160;</p><p>The panelists presented the latest available science on the effects and content of e-cigarettes and suggested approaches to halting the concerning rise in youth vaping and nicotine addiction.&#160;</p><p>A video of the full briefing is available here&#58; <a href="https&#58;//youtu.be/l0TxoLOQq4c" target="_blank">https&#58;//youtu.be/l0TxoLOQq4c</a></p><p>You can read a summary of the briefing on the AACR’s blog&#58; <a href="https&#58;//blog.aacr.org/aacr-holds-congressional-briefing-on-strengthening-prevention-of-e-cigarette-use-in-youth/" target="_blank">https&#58;//blog.aacr.org/aacr-holds-congressional-briefing-on-strengthening-prevention-of-e-cigarette-use-in-youth/</a></p><p>Sen. Dick Durbin (D-Illinois) and Rep. Jackie Speier (D-California) were the honorary congressional co-chairs. In inspiring opening remarks, Durbin discussed how the loss of his father to lung cancer sparked his passion for ending the scourge of tobacco.</p><p>Roy S. Herbst, MD, PhD, chair of the AACR’s Tobacco and Cancer Subcommittee and chief of medical oncology at the Yale Cancer Center, moderated the briefing. Other speakers included&#58;</p><ul><li>Rachel Grana Mayne, PhD, MPH, a program director in the Tobacco Control and Research Branch at the National Cancer Institute and an expert on e-cigarette research;<br><br></li><li>Brian Maslowski, an alcohol, tobacco, and other drug instructor from the Fairfax County Public Schools’ Office of Student Safety and Wellness with a wealth of direct experience on the context in which high school and middle school students are using e-cigarettes;<br><br></li><li>Jia Tolentino, a staff writer at The New Yorker, whose recent in-depth article, “The Promise of Vaping and the Rise of Juul,” chronicled the recent rise of “juuling” among high school and college students; and<br><br></li><li>Benjamin Toll, PhD, member of the AACR’s Tobacco and Cancer Subcommittee and chief of Tobacco Cessation and Health Behaviors at the Hollings Cancer Center, an expert on novel smoking cessation treatments.</li></ul><p>To schedule interviews with the panelists, contact Julia Gunther at <a href="mailto&#58;julia.gunther@aacr.org">julia.gunther@aacr.org</a> or 215-446-6896.<br></p></div>
Webcasts Available: Renowned Cancer Researchers Present at the AACR’s International Lymphoma Meeting in Boston198406/28/2018 6:13:31 PMhttps://www.aacr.org/Newsroom/Lists/Media Advisories/AllItems.aspx102False2018-06-27T04:00:00Z<div class="ExternalClass8C2D60CB91F14E0483A887F9E3E294CC"><p>The American Association for Cancer Research (AACR) recently hosted the<a href="/Meetings/Pages/MeetingDetail.aspx?EventItemID=147"> Inaugural AACR International Meeting&#58; Advances in Malignant Lymphoma</a> in Boston. Presented in cooperation with the International Conference on Malignant Lymphoma (ICML), the program provided a forum for discussion and brainstorming about how recent advances and emerging areas of lymphoma research hold enormous potential for transforming clinical care.&#160;<br></p><p>The meeting featured keynote addresses from several renowned cancer researchers. Their presentations are now available as webcasts&#58;<br></p><div><ul><li><p>Michael Caligiuri, MD, AACR Past President and City of Hope National Medical Center, presented a talk titled “Immunogenicity Predicts Prevention.&quot;&#160;<a href="http&#58;//webcast.aacr.org/p/2018lym/28" target="_blank">Watch&#160;the webcast</a>. <br></p></li></ul></div><div><ul><li><p>James Allison, PhD, The University of Texas MD Anderson Cancer Center, presented a talk titled “Immune Checkpoint Blockade in Cancer Therapy&#58; New Insights, Opportunities, and Prospects for Cures.” <a href="http&#58;//webcast.aacr.org/p/2018lym/126" target="_blank">Watch&#160;the webcast</a>.&#160;<br></p></li></ul></div><div><ul><li><p>Kenneth Anderson, MD, Dana-Farber Cancer Institute, presented a talk titled “Targeting Achilles’ Heels in Multiple Myeloma.&quot; <a href="http&#58;//webcast.aacr.org/p/2018lym/283" target="_blank">Watch&#160;the webcast. </a><br></p></li></ul></div><p>Interviews with these experts, meeting chair Ari Melnick, MD, or others who presented at this meeting can be arranged. Contact Julia Gunther at <a href="mailto&#58;julia.gunther@aacr.org">julia.gunther@aacr.org</a> or 215-446-6896.<br></p><p><a href="http&#58;//blog.aacr.org/qa-with-ari-m-melnick-md-on-recent-advances-in-lymphoma/">Read a Q&amp;A </a>with Dr. Melnick about the meeting on the AACR’s blog, <em>Cancer Research Catalyst.</em>&#160;<br></p><p>See the <a href="/Meetings/Pages/MeetingDetail.aspx?EventItemID=147&amp;DetailItemID=756">full program</a>&#160;and the <a href="http&#58;//www.abstractsonline.com/pp8/#%21/5739" target="_blank">abstracts</a>.</p><div><br></div></div>
AACR to Host Inaugural International Meeting on Advances in Malignant Lymphoma198396/11/2018 9:05:20 PMhttps://www.aacr.org/Newsroom/Lists/Media Advisories/AllItems.aspx101False2018-06-11T20:45:00Z<div class="ExternalClass31104E45BF8A48C290E123D3BED1DB51"><p>​The American Association for Cancer Research (AACR) will host its <a href="http&#58;//link.email.dynect.net/link.php?DynEngagement=true&amp;H=oGJ1pkZyysOST8btnWeAdWfazdP60O3PLkuOZioW2RiI0IVhceklygFHMnqT9mcAyt1hDCcUrpx48F75qhgyFQZ06iVCinohqzd/kJiWMHKzq2gJYUgmOweRaVRw9vyq&amp;G=0&amp;R=http&#58;//www.aacr.org/Meetings/Pages/MeetingDetail.aspx?EventItemID%3D147&amp;I=20180611203722.00000058b635%40mail6-94-usnbn1&amp;X=MHwxMDQ2NzU4OjViMWVkZDJhNmZiMjNkMGEwOTQzY2Y0MDs%3D&amp;S=eXqEJl1NfqkXiU1xcA78JEtrwfT5VyAQJu5yuSpKUU8" target="_blank">Inaugural AACR International Meeting&#58; Advances in Malignant Lymphoma</a> later this month in Boston. Presented in cooperation with the International Conference on Malignant Lymphoma (ICML), this program will provide a forum for discussion and brainstorming about how recent advances and emerging areas of lymphoma research hold enormous potential for transforming clinical care.&#160;</p><p>The meeting is designed to be highly interactive and presents a unique opportunity to engage with international leaders in lymphoma research. Topics to be discussed include immunotherapy, targeted therapy, CRISPR screening, liquid biopsy, and studying canine lymphoma to develop treatments that will benefit dogs and humans.</p><p>The program will feature keynote addresses from renowned cancer researchers&#58;</p><p>On Friday, June 22, from 6-8 p.m. ET,<br><strong>•&#160;Michael Caligiuri, MD</strong>, City of Hope National Medical Center and Past President of the AACR, will present a talk titled “Immunogenicity Predicts Prevention,” and<br><strong>•&#160;Carl June, MD</strong>, University of Pennsylvania and member of the AACR Board of Directors, will present a talk titled “CAR T for Lymphoma and Beyond.”</p><p>On Tuesday, June 26, from 8-10 a.m. ET, <br><strong>•&#160;James Allison, PhD</strong>, The University of Texas MD Anderson Cancer Center, will present a talk titled “Immune Checkpoint Blockade in Cancer Therapy&#58; New Insights, Opportunities, and Prospects for Cures,” and <br><strong>•&#160;Kenneth Anderson, MD</strong>, Dana-Farber Cancer Institute, will present a talk titled “Targeting Achilles Heels in Multiple Myeloma.”</p><p>The keynote addresses will be available as webcasts within 24 hours of presentation.</p><p>Reporters may register for the meeting and complimentary access to the webcasts by contacting Julia Gunther at <a href="mailto&#58;julia.gunther@aacr.org">julia.gunther@aacr.org</a> or 215-446-6896.</p><p>To learn more about the meeting, watch <a href="http&#58;//link.email.dynect.net/link.php?DynEngagement=true&amp;H=oGJ1pkZyysOST8btnWeAdWfazdP60O3PLkuOZioW2RiI0IVhceklygFHMnqT9mcAyt1hDCcUrpx48F75qhgyFQZ06iVCinohqzd/kJiWMHKzq2gJYUgmOweRaVRw9vyq&amp;G=0&amp;R=https&#58;//youtu.be/TKHxV7cQe1Q&amp;I=20180611203722.00000058b635%40mail6-94-usnbn1&amp;X=MHwxMDQ2NzU4OjViMWVkZDJhNmZiMjNkMGEwOTQzY2Y0MDs%3D&amp;S=ZMDBs2djYOigaMX66rLkc6JEDcFdvrMi5EOIDIWXSQc" target="_blank">this interview </a>with meeting chair Ari Melnick, MD. Visit the meeting website <a href="http&#58;//link.email.dynect.net/link.php?DynEngagement=true&amp;H=oGJ1pkZyysOST8btnWeAdWfazdP60O3PLkuOZioW2RiI0IVhceklygFHMnqT9mcAyt1hDCcUrpx48F75qhgyFQZ06iVCinohqzd/kJiWMHKzq2gJYUgmOweRaVRw9vyq&amp;G=0&amp;R=http&#58;//www.aacr.org/Meetings/Pages/MeetingDetail.aspx?EventItemID%3D147%26DetailItemID%3D744&amp;I=20180611203722.00000058b635%40mail6-94-usnbn1&amp;X=MHwxMDQ2NzU4OjViMWVkZDJhNmZiMjNkMGEwOTQzY2Y0MDs%3D&amp;S=wthwbsgE7FLyq7gz24JLqGhbUxu3MDq3-phTh2AFMUk">here</a>.</p><p><strong>WHEN&#58;</strong><br>June 22-26, 2018</p><p><strong>WHERE&#58;</strong><br>Boston Marriott Copley Place <br>110 Huntington Avenue<br>Boston, MA 02116</p><p><strong>PROGRAM&#58;</strong><br>Read the full program here.<br>Interviews can be arranged per the availability of the speakers.</p></div>
FDA, AACR, and SGO to Present Workshop on Gynecologic Malignancies198386/5/2018 6:07:04 PMhttps://www.aacr.org/Newsroom/Lists/Media Advisories/AllItems.aspx100False2018-06-05T17:00:00Z<div class="ExternalClass3923E7A76C934267A0A70986525FE4DE"><p>​The U.S. Food and Drug Administration (FDA), the American Association for Cancer Research (AACR), and the Society of Gynecologic Oncology (SGO) present a workshop on drug development in gynecologic malignancies, a major cause of morbidity and mortality in the United States. </p><p>This workshop is designed to facilitate open discussion between the FDA, clinicians, laboratory experts, researchers, and patients on the way forward for diagnosis and treatment of gynecologic malignancies. Sessions will focus on immunotherapy, biomarkers, and novel study designs for rare subtypes.</p><p><strong>WHEN&#58;</strong><br>Thursday, June 14<br>8 a.m.-5 p.m. ET<br>In-person or live stream attendance is free but advance registration is requested. RSVP to Julia Gunther at <a href="mailto&#58;julia.gunther@aacr.org">julia.gunther@aacr.org</a> or 215-446-6896.</p><p><strong>WHERE&#58;</strong><br>FDA White Oak Campus<br>Great Room A<br>10903 New Hampshire Avenue<br>Silver Spring, MD 20993</p><p><strong>Transportation to FDA&#58;</strong> Information about public meetings at White Oak, including directions and parking, can be found here. Please allow time to locate parking (parking map), use the shuttle to Building 1, go through routine security procedures, and sign in. All visitors should park in Northwest Surface Lot 1, 3, or 4.</p><p><strong>SPEAKERS AND PROGRAM&#58;</strong><br>Interviews can be arranged per the availability of the speakers.</p><p><strong>Workshop Co-chairs&#58;</strong><br><strong>•&#160;FDA&#58;</strong><br><strong>•&#160;Sanjeeve Bala, MD, MPH</strong>, Clinical Team Leader Gynecologic Malignancies Group, Division of Oncology Products 1 (DOP1), Office of Hematology and Oncology Products (OHOP), Center for Drug Evaluation and Research (CDER), FDA<br><strong>•&#160;Julia A. Beaver, MD</strong>, Director, Division of Oncology Products 1 (DOP1), Office of Hematology and Oncology Products (OHOP), Center for Drug Evaluation and Research (CDER), FDA<br><strong>•&#160;AACR</strong>&#58;<br><strong>•&#160;Deborah K. Armstrong, MD</strong>, Director, Breast and Ovarian Surveillance Service; Professor of Oncology, John Hopkins Kimmel Comprehensive Cancer Center<br><strong>•&#160;Gordon B. Mills, MD, PhD</strong>, Member, AACR Board of Directors; Co-Director, Zayed Institute for Personalized Cancer Therapy, Department of Systems Biology 1, Division of Cancer Medicine, UT MD Anderson Cancer Center<br><strong>•&#160;Society of Gynecologic Oncology (SGO)&#58;</strong><br><strong>•&#160;Rebecca Arend, MD</strong>, Assistant Professor of Obstetrics &amp; Gynecology, University of Alabama at Birmingham<br><strong>•&#160;Robert Coleman, MD, FACOG, FACS</strong>, Vice Chair, Clinical Research, Department of Gynecologic Oncology and Reproductive Medicine, UT MD Anderson Cancer Center<br><strong>•&#160;Thomas Herzog, MD</strong>, Deputy Director and Professor of Obstetrics &amp; Gynecology, University of Cincinnati Cancer Institute</p><p><strong>Program&#58;</strong><br><strong>8&#58;20–9&#58;55 a.m.&#58; </strong>Development of Immunotherapy in Gynecological Malignancies – Part 1</p><p><strong>10&#58;10–11&#58;55 a.m.&#58; </strong>Development of Immunotherapy in Gynecological Malignancies – Part 2</p><p><strong>1–2&#58;35 p.m.&#58;</strong> Biomarker Development and PARP Inhibitors</p><p><strong>2&#58;50–4&#58;35 p.m.&#58; </strong>Development of Drugs for Rare Gynecological Malignancies</p><p><a href="/AdvocacyPolicy/GovernmentAffairs/Documents/FDA%20AACR%20SGO%20Gyn%20Malignancies%20Workshop%20Agenda.pdf">Read </a>the full draft agenda.<br></p></div>
AACR Annual Meeting 2018 Science and Regulatory Policy Sessions199324/11/2018 6:40:50 PMhttps://www.aacr.org/Newsroom/Lists/Media Advisories/AllItems.aspx99False2018-04-11T18:00:00Z<div class="ExternalClass3C1CE1652A3740EFAFE662D5DF7F0195"><p>​The American Association for Cancer Research (AACR) will be hosting its 109th Annual Meeting, April 14-18, 2018, at McCormick Place North/South in Chicago, bringing together more than 22,000 scientists, clinicians, advocates, and other attendees from around the world. In addition to a myriad of cancer research sessions, the AACR Annual Meeting will also feature a robust science policy and regulatory track. Key panel discussions are highlighted below&#58;</p><p><strong>The Cancer Survivorship Landscape&#58; Potential Focus Areas for the Future<br></strong>Sunday, April 15, 2018 | 5 – 6&#58;30 p.m.<br><em>Room W190 - McCormick Place West (Level 1) </em><br><strong>Anna D. Barker, PhD</strong> - Arizona State University, Scottsdale<br><strong>Greg J. Aune, MD, PhD</strong> - Children’s Cancer Research Institute, San Antonio<br><strong>Shelley Fuld Nasso, MPP</strong> - National Coalition for Cancer Survivorship, Silver Spring, Maryland <br><strong>Brenda M. Nevidjon, MSN, RN, FAAN</strong> - Oncology Nursing Society, Pittsburgh<br><strong>Julia H. Rowland, PhD</strong> - National Cancer Institute, Bethesda, Maryland <br><strong>Julie K. Silver, MD</strong> - Harvard Medical School, Boston<br><strong>Patty Spears</strong> - UNC Lineberger Comprehensive Cancer Center, Chapel Hill, North Carolina<br><strong>Doug Ulman</strong> - Pelotonia, Columbus, Ohio</p><p><strong>A Town Hall Discussion of AACR’s Priorities in Tobacco Policy </strong><br>Monday, April 16, 2018 | 1 – 2&#58;45 p.m.<br><em>Room S401bcd - McCormick Place South (Level 4)</em><br><strong>Roy S. Herbst, MD, PhD (Chair)</strong> - Yale Cancer Center, New Haven, Connecticut <br><strong>Cathy L. Backinger, PhD, MPH</strong> – U.S. Food and Drug Administration, Silver Spring, Maryland<br><strong>Michele Bloch, MD, PhD</strong> - National Cancer Institute, Bethesda, Maryland <br><strong>Dorothy K. Hatsukami, PhD</strong> - University of Minnesota, Minneapolis<br><strong>Brian A. King, PhD, MPH</strong> - Centers for Disease Control and Prevention, Atlanta<br><strong>Christopher S. Lathan, MD, MS, MPH</strong> - Dana-Farber Cancer Institute, Boston</p><p><strong>NCI Director’s Address and Fireside Chat with AACR Leaders</strong><br>This session will be streamed via Facebook Live. Live stream can be accessed at <a href="http&#58;//facebook.com/aacr.org" target="_blank">http&#58;//facebook.com/aacr.org</a>. <br>Monday, April 16, 2018 | 3 – 3&#58;45 p.m.<br><em>Room W190 - McCormick Place West (Level 1) </em><br><strong>Norman E. Sharpless, MD</strong> - National Cancer Institute, Bethesda, Maryland <br><strong>Michael A. Caligiuri, MD</strong> – AACR President, City of Hope National Medical Center, Duarte, California <br><strong>Elizabeth M. Jaffee, MD</strong> – AACR President-Elect, Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, Baltimore</p><p><strong>Biden Cancer Initiative Colloquium</strong> <br>This session will be streamed via Periscope. Live stream can be accessed at <a href="http&#58;//twitter.com/aacr" target="_blank">http&#58;//twitter.com/aacr</a>. <br>Tuesday, April 17, 2018 5 – 6&#58;30 p.m.<br><em>Room S401bcd - McCormick Place South (Level 4)</em><br><strong>Elizabeth M. Jaffee, MD</strong> – AACR President-Elect, Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, Baltimore<br><strong>Gregory C. Simon, JD</strong> - Biden Cancer Initiative, Washington, D.C.<br><strong>Stanton L. Gerson, MD</strong> - Case Comprehensive Cancer Center, Cleveland<br><strong>Jay Holley </strong>- Uber Health, San Francisco<br><strong>Carla Tardif</strong> - Family Reach, Boston<br><strong>Louis J. DeGennaro, PhD</strong> - Leukemia &amp; Lymphoma Society, White Plains, New&#160;&#160;York <br><strong>&#160;Patricia M. Doykos, PhD</strong> - Bristol-Myers Squibb Foundation, New York<br><strong>&#160;Asif Dhar, MD, MBA</strong> - Deloitte Consulting, Washington, D.C.&#160; </p><p><br>&#160;</p></div>
AACR Announces Press Conference Schedule for Annual Meeting 2018 in Chicago199312/7/2018 6:29:52 PMhttps://www.aacr.org/Newsroom/Lists/Media Advisories/AllItems.aspx98False2018-02-07T05:00:00Z<div class="ExternalClassB48B2088D7A349F4A2167D3F2CC9DD7A"><p>​The American Association for Cancer Research (AACR) will be hosting its 109th <a href="http&#58;//media.ne.cision.com/l/tmfpafly/www.aacr.org/Meetings/Pages/MeetingDetail.aspx?EventItemID=136" target="_blank">Annual Meeting</a>, April 14-18, 2018, at McCormick Place North/South in Chicago, Illinois. </p><p>The official AACR Annual Meeting press program will feature high-impact science that strengthens our understanding of cancer, as well as clinical trial results that highlight new treatment options and promise for cancer patients. </p><p>The press program will include three press conferences at the following times&#58;</p><p>•&#160;Sunday, April 15, 8&#58;30 a.m. CT<br>•&#160;Monday, April 16, 8&#58;30 a.m. CT<br>•&#160;Tuesday, April 17, 8&#58;30 a.m. CT</p><p>A call-in number will be available for reporters who cannot travel to Chicago. The press conference presentations will be announced closer to the meeting.</p><p>The press room will be open&#58; </p><p>•&#160;Saturday, April 14, 8 a.m.-6 p.m. CT<br>•&#160;Sunday, April 15-Tuesday, April 17, 7&#58;30 a.m.-6 p.m. CT<br>•&#160;Wednesday, April 18, 7&#58;30 a.m.-12 p.m. CT</p><p>Registration is complimentary for credentialed news media. Members of the media can register by contacting Julia Gunther at <a href="mailto&#58;julia.gunther@aacr.org" target="_blank">julia.gunther@aacr.org</a> or 215-446-6896. Reporters planning to cover remotely should contact Julia Gunther as well so that they receive all relevant communications sent before and during the meeting.</p><p>Public information officers at medical institutes and cancer centers (limit two PIOs per institution) can also register by contacting Julia Gunther.</p><p>To make a hotel reservation, visit the AACR’s housing site at <a href="https&#58;//www5.cmrhousing.com/aacr2018/Housing/ResHotel" target="_blank">https&#58;//www5.cmrhousing.com/aacr2018/Housing/ResHotel</a>. We recommend adding your name to the waitlist as soon as possible. We are currently on track to accommodate waitlist requests within the next month. </p><p>The AACR Annual Meeting has an anticipated attendance of more than 22,000 scientists, clinicians, advocates, and other attendees from around the world. With this year’s theme, “Driving Innovative Cancer Science to Patient Care,” the scientific program includes an outstanding roster of world-class speakers, hundreds of invited talks, and more than 6,000 proffered papers. Presentations at the AACR Annual Meeting will span the entire field of cancer research, highlighting basic, translational, and clinical research on important topics such as immunotherapy, targeted therapy, artificial intelligence, liquid biopsy, early detection, cancer interception, prevention, and survivorship. This year’s meeting also features a robust science policy and regulatory track as well as new cancer health disparities sessions. </p><p>View the meeting program <a href="http&#58;//media.ne.cision.com/l/tmfpafly/www.aacr.org/Meetings/Pages/MeetingDetail.aspx?EventItemID=136&amp;DetailItemID=711" target="_blank">here</a>. Those following on social media can join the conversation on Twitter at #AACR18.</p><p>This year’s press program will be managed by Julia Gunther, assistant director, media and public relations, <a href="mailto&#58;julia.gunther@aacr.org" target="_blank">julia.gunther@aacr.org</a> or 215-446-6896; Rachel Salis-Silverman, director, public relations, <a href="mailto&#58;rachel.silverman@aacr.org" target="_blank">rachel.silverman@aacr.org</a> or 215-446-7159; and Rick Buck, senior director, communications and public relations, <a href="mailto&#58;rick.buck@aacr.org" target="_blank">rick.buck@aacr.org</a> or 215-446-7162.</p></div>
American Association for Cancer Research to Host 2018 Annual Meeting in Chicago, April 14-18199301/25/2018 6:37:52 PMhttps://www.aacr.org/Newsroom/Lists/Media Advisories/AllItems.aspx97False2018-01-22T19:30:00Z<div class="ExternalClass619D17FB3B124C35AE723BC4783FE58B"><p>The American Association for Cancer Research (AACR) will be hosting its 109th <a href="http&#58;//media.ne.cision.com/l/kyfwfegz/www.aacr.org/Meetings/Pages/MeetingDetail.aspx?EventItemID=136">Annual Meeting</a>, April 14-18, 2018, at McCormick Place North/South in Chicago, Illinois. </p><p>The AACR Annual Meeting has an anticipated attendance of more than 22,000 scientists, clinicians, advocates, and other attendees from around the world. With this year's theme, &quot;Driving Innovative Cancer Science to Patient Care,&quot; the scientific program includes an outstanding roster of world-class speakers, hundreds of invited talks, and more than 6,000 proffered papers. Presentations at the AACR Annual Meeting will span the entire field of cancer research, highlighting basic, translational, and clinical research on important topics such as immunotherapy, targeted therapy, artificial intelligence, liquid biopsy, early detection, cancer interception, prevention, and survivorship. This year's meeting also features a robust science policy and regulatory track as well as new cancer health disparities sessions. </p><p>The AACR press program will feature high-impact science that strengthens our understanding of cancer, as well as clinical trial results that highlight new treatment options and promise for cancer patients. The press conference schedule will be released in the next few weeks.</p><p><a href="http&#58;//media.ne.cision.com/l/kyfwfegz/www.aacr.org/Meetings/Pages/MeetingDetail.aspx?EventItemID=136&amp;DetailItemID=711" target="_blank">View the meeting program</a>. </p><p>Registration is complimentary for credentialed news media. Members of the media can register by contacting Julia Gunther at julia.gunther@aacr.org or 215-446-6896. Hotel information can be found on the AACR's <a href="http&#58;//media.ne.cision.com/l/kyfwfegz/www.aacr.org/Meetings/Pages/MeetingDetail.aspx?EventItemID=136&amp;DetailItemID=710" target="_blank">website</a>. </p><p>Reporters planning to cover remotely should register so that they receive all relevant communications sent out by the AACR Department of Communications and Public Relations before and during the meeting.</p><p>Public information officers at medical institutes and cancer centers (limit two PIOs per institution) can also register by contacting Julia Gunther.</p><p>Those following on social media can join the conversation on Twitter at <a href="http&#58;//media.ne.cision.com/l/kyfwfegz/www.twitter.com/hashtag/aacr18" target="_blank">#AACR18</a>.</p><p>This year's press program will be managed by Julia Gunther, assistant director, media and public relations, julia.gunther@aacr.org or 215-446-6896; Rachel Salis-Silverman, director, public relations, rachel.silverman@aacr.org or 215-446-7159; and Rick Buck, senior director, communications and public relations, rick.buck@aacr.org or 215-446-7162.</p><p>&#160;</p></div>